Amazines Free Article Archive
www.amazines.com - Thursday, May 19, 2022
Read about the most recent changes and happenings at Amazines.com
Log into your account or register as a new author. Start submitting your articles right now!
Search our database for articles.
Subscribe to receive articles emailed straight to your email account. You may choose multiple categories.
View our newest articles submitted by our authors.
View our most top rated articles rated by our visitors.
* Please note that this is NOT the ARTICLE manager
Add a new EZINE, or manage your EZINE submission.
Add fresh, free web content to your site such as newest articles, web tools, and quotes with a single piece of code!
Home What's New? Submit/Manage Articles Latest Posts Top Rated Article Search
Google
Subscriptions Manage Ezines
CATEGORIES
 Article Archive
 Advertising (133513)
 Advice (161570)
 Affiliate Programs (34788)
 Art and Culture (73834)
 Automotive (145676)
 Blogs (75389)
 Boating (9851)
 Books (17221)
 Buddhism (4129)
 Business (1329911)
 Business News (426411)
 Business Opportunities (366439)
 Camping (10969)
 Career (72776)
 Christianity (15844)
 Collecting (11639)
 Communication (115069)
 Computers (241908)
 Construction (38920)
 Consumer (49947)
 Cooking (17078)
 Copywriting (6730)
 Crafts (18205)
 Cuisine (7547)
 Current Affairs (20307)
 Dating (45901)
 EBooks (19700)
 E-Commerce (48246)
 Education (185371)
 Electronics (83517)
 Email (6439)
 Entertainment (159836)
 Environment (28922)
 Ezine (3040)
 Ezine Publishing (5452)
 Ezine Sites (1550)
 Family & Parenting (110928)
 Fashion & Cosmetics (196538)
 Female Entrepreneurs (11851)
 Feng Shui (132)
 Finance & Investment (310496)
 Fitness (106442)
 Food & Beverages (63005)
 Free Web Resources (7939)
 Gambling (30224)
 Gardening (25192)
 Government (10512)
 Health (629863)
 Hinduism (2206)
 Hobbies (44078)
 Home Business (91593)
 Home Improvement (251114)
 Home Repair (46208)
 Humor (4717)
 Import - Export (5456)
 Insurance (45103)
 Interior Design (29588)
 International Property (3488)
 Internet (191001)
 Internet Marketing (146657)
 Investment (22855)
 Islam (1161)
 Judaism (1352)
 Law (80455)
 Link Popularity (4596)
 Manufacturing (20900)
 Marketing (99266)
 MLM (14140)
 Motivation (18232)
 Music (26996)
 New to the Internet (9496)
 Non-Profit Organizations (4048)
 Online Shopping (129726)
 Organizing (7809)
 Party Ideas (11853)
 Pets (38070)
 Poetry (2229)
 Press Release (12687)
 Public Speaking (5639)
 Publishing (7561)
 Quotes (2407)
 Real Estate (126590)
 Recreation & Leisure (95455)
 Relationships (87647)
 Research (16180)
 Sales (80345)
 Science & Technology (110280)
 Search Engines (23494)
 Self Improvement (153285)
 Seniors (6216)
 Sexuality (35996)
 Small Business (49286)
 Software (83017)
 Spiritual (23466)
 Sports (116146)
 Tax (7659)
 Telecommuting (34072)
 Travel & Tourism (308161)
 UK Property Investment (3122)
 Video Games (13382)
 Web Traffic (11758)
 Website Design (56862)
 Website Promotion (36613)
 World News (1000+)
 Writing (35833)
Author Spotlight
HANVEY HUANG

I'm a Chief Operated Officer from KIMKOO Mattress machinery.The pen is mightier than the sword.so I ...more
JOHN WHARTON

img border="0" height="22" src="3.bp.blogspot.com/-lwbCHWyiaZE/UkU4PxcWj8I/AAAAAAAAAA0/QooVAHCHbx4/...more
RAM SEWAK

Myself Ram Sewak possessing indepth domain experience of more than 10 years in SEO, SEM, Web Develop...more
SANTOSH GUPTHA

Certified Medical coder with 42 certifications,15 years experience in Medical records coding, HIPAA,...more
JASON STEVE

Writing is my passion, Social media marketing is my love. I have written many articles on various ni...more


Global Competitors Introducing Various Cognitive Impairment Disorder Drugs to Boost Market Growth - by Ankur Gupta





Article Author Biography
Global Competitors Introducing Various Cognitive Impairment Disorder Drugs to Boost Market Growth - by
Article Posted: 05/11/2018
Article Views: 305
Articles Written: 1063
Word Count: 579
Article Votes: 0
AddThis Social Bookmark Button

Global Competitors Introducing Various Cognitive Impairment Disorder Drugs to Boost Market Growth -


 
Health
Cognitive impairment is not an illness, but a condition of the body. The patient has trouble with memory or paying attention, trouble speaking or understanding, difficulty in recognising people, places or things, and might find new places or situations overwhelming. Cognitive impairment patient is confused, agitated, or very moody. This situation can come and go which is known as delirium. The cognitive impairment disorder can be mild, or severe, or anything in between, temporary problem or a permanent condition. The major causes of temporary cognitive impairment are infections, such as a urinary tract infection or pneumonia, vitamin deficiency, dehydration, and reactions to medications. Few causes of permanent cognitive impairment are dementia, stroke and brain injury. Not every aged person will have cognitive impairment; however, cognitive impairment is more common in older people. It can be both genetic and acquired, and brain damage caused via accidents. According to the study “Cognitive Impairment Disorders Drug Development Pipeline Review, 2018”, if left untreated, cognitive impairment disorder can worsen along with the possibility of other mental problems; therefore, various treatment options and a wide range of drugs are available. Globally, therapeutics or drugs for cognitive impairment are still under development. The key players involved in therapeutic or drug development for cognitive impairment are associated with schizophrenia (CIAS), dementia, mild cognitive impairment and Alzheimer's disease. Drugs for cognitive impairment disorders are small molecules, due to their ability to cross the blood-brain barrier and their proven commercial success. Majority of products are neuromodulators, impacting the dopaminergic, serotonergic and glutamatergic systems. There is diversity within each drug in terms of molecule type and molecular targets. Human central nervous system (CNS) is complex and highly sophisticated in nature. Pathophysiology of cognitive impairment disorders is not well understood in the medical sciences. Therefore, treatment options are limited, and the available drugs in the market act by slowing the disease progression or treating symptoms. The various drugs still under development for cognitive impairment disorders are above 800, respectively. The leading players in the global cognitive impairment disorders drugs development are Eli Lilly and Co., Bristol-Myers Squibb, Pfizer, AstraZeneca, AB Science SA, AbbVie Inc, Aucta Pharmaceuticals LLC, Avineuro Pharmaceuticals Inc, CereSpir Inc, CHA Bio & Diostech Co Ltd, CohBar Inc, Connexios Life Sciences Pvt Ltd, Cypralis Ltd, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Dongkook Pharmaceutical Co Ltd, Dr. August Wolff GmbH & Co KG Arzneimittel, Echo Pharmaceuticals BV, Eisai Co Ltd, Epigen Biosciences Inc, GlaxoSmithKline Plc, Golden Biotechnology Corp, Grifols SA, ID Pharma Co Ltd, Immungenetics AG, Kyowa Hakko Kirin Co Ltd, Lead Discovery Center GmbH, Merck & Co Inc, Microlin Bio Inc, ModGene Pharma LLC, Octapharma AG, Oryzon Genomics SA, Otsuka Holdings Co Ltd, Ovensa Inc, Prevacus Inc, ProMIS Neurosciences Inc, and Voyager Therapeutics Inc. It was observed that cognitive impairment disorders will increase significantly over the next few years due to increase in aging population. Therefore, there is a strong need to develop new drugs that effectively treat symptoms and target the underlying mechanisms of disease. The advanced technology in medical sciences is encouraging cognitive impairment disorders drug development worldwide. With more players in this category, more variants of drugs are introduced for the treatment of cognitive impairment disorders. This trend will continue over the next few years due to increasing instances of cognitive impairment disorders among all age groups. To know more, click on the link below: https://www.kenresearch.com/healthcare/general-healthcare/cognitive-impairment-disorders-drug-development-pipeline-review/149105-91.html Related Reports: https://www.kenresearch.com/healthcare/pharmaceuticals/pharmapoint-painful-diabetic-neuropathy-global-drug-forecast-and-market-analysis-to-2026/149179-91.html https://www.kenresearch.com/healthcare/pharmaceuticals/mitogen-activated-protein-kinase-14-cytokine-suppressive-anti-inflammatory-drug-binding-protein-or-mitogen-activated-protein-kinase-p38-alpha-or-map-kinase-mxi2-or-max-interacting-protein-2-or-stress-activated-protein-kinase-2a-or-mapk14-or-ec-2-7-11-24-/149141-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com 0124-4230204


Related Articles - Alzheimer Disease Drug Development Market, Global Disease Drug Development Industry,

Email this Article to a Friend!

Receive Articles like this one direct to your email box!
Subscribe for free today!

 Rate This Article  
Completely useless, should be removed from directory.
Minimal useful information.
Decent and informative.
Great article, very informative and helpful.
A 'Must Read'.

 

Do you Agree or Disagree? Have a Comment? POST IT!

 Reader Opinions 
Submit your comments and they will be posted here.
Make this comment or to the Author only:
Name:
Email:
*Your email will NOT be posted. This is for administrative purposes only.
Comments: *Your Comments WILL be posted to the AUTHOR ONLY if you select PRIVATE and to this PUBLIC PAGE if you select PUBLIC, so write accordingly.
 
Please enter the code in the image:



 Author Login 
LOGIN
Register for Author Account

 

Advertiser Login

 

ADVERTISE HERE NOW!
   Limited Time $60 Offer!
   90  Days-1.5 Million Views  

 

Great Paranormal Romance


STEPHEN BYE

Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through The...more
SHALINI MITTAL

A postgraduate in Fashion Technology. Shalini is a writer at heart! Writing for her is an expression...more
LAURA JEEVES

At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
STEVERT MCKENZIE

Stevert Mckenzie, Travel Enthusiast. ...more
GENE MYERS

Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
ALEX BELSEY

I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
NEVIO GARDASANIC

Hello, my name is Nevio Gardasanic. If you want to go beyond being just a perpetual beginner at thin...more
SANJIB DAS

Sanjib Kumar Das is an Indian business enthusiast and entrepreneur who is motivated to help small an...more
AKSHAY CHOPRA

Akshay Chopra is an experienced certified personal trainer and the founder of WERSTUID. An organizat...more
TIM FAY

I am not a writer nor am I trying to become a writer. I am an average person with average intelligen...more

HomeLinksAbout UsContact UsTerms of UsePrivacy PolicyFAQResources
Copyright © 2022, All rights reserved.
Some pages may contain portions of text relating to certain topics obtained from wikipedia.org under the GNU FDL license